

HYZAAR is indicated for:
Management of hypertension to lower blood pressure and reduce cardiovascular risk.
Reduction of stroke risk in hypertensive patients with left ventricular hypertrophy, though this benefit has not been demonstrated in Black patients.
Hypertension: Initiate with 50/12.5 mg once daily. Titrate to a maximum of 100/25 mg based on response.
Hypertension with Left Ventricular Hypertrophy: Begin with 50/12.5 mg if monotherapy is insufficient. Titrate up to 100/25 mg as needed.
Dose adjustments should be made at approximately 3-week intervals.
Losartan Potassium and Hydrochlorothiazide Tablets (Hyzaar) is a combined antihypertensive drug manufactured by...
Losartan Potassium and Hydrochlorothiazide Tablets (Hyzaar) is a combined antihypertensive drug composed of losartan...
Losartan Potassium and Hydrochlorothiazide Tablets (Hyzaar) is a fixed-dose combination of losartan (an angiotensin...
Losartan Potassium and Hydrochlorothiazide Tablets (Hyzaar) is a combined antihypertensive drug composed of losartan...
Losartan Potassium and Hydrochlorothiazide Tablets (Hyzaar) is a compound antihypertensive medication composed of...
Losartan Potassium and Hydrochlorothiazide Tablets (Hyzaar) is a compound antihypertensive drug composed of losartan...
